Abstract
The plasma concentrations of dehydroepiandrosterone (DHA) sulphate and 11β-hydroxycorticosteroids ( 11-OHCS) were studied in groups of women with benign breast disease and those with primary and advanced breast cancer. Statistical analysis of the results obtained revealed that there was no difference in the levels of plasma 11-OHCS in the various groups of patients. However, patients with advanced breast cancer had lower plasma concentrations of DHA sulphate when compared to each of the other groups. The difference between the advanced and benign groups achieved significance (p < 0.05).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
